Home » The Scan » 'Not Dead Yet'

'Not Dead Yet'

Nov 23, 2011

At The New York Times' Prescriptions blog, Andrew Pollack says RNA interference "might not be dead yet." That Alnylam Pharmaceuticals recently announced it had established proof of concept for the efficacy of an RNAi-based drug in a phase 1 clinical trial "at least points to the possibility that the approach can be used in people," Pollack says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.